United We Stand Against COVID-19
Zymo Research is supporting the COVID-19 efforts around the world by providing sample collection, extraction, and an RT-PCR workflow for COVID-19 testing.
The SARs-CoV-2 Testing Workflow
From Collection to Analysis
Sample Collection
- Complete pathogen inactivation
- Protect RNA in samples at room temp.
- Automation and RNA purification kit compatible
Viral RNA Extraction
- Process 96 samples in 1-2 hours
- Quality RNA for RT-qPCR, NGS, etc.
- Automation-ready
Covid-19 Detection
- Highly specific SARS-CoV-2 rRT-PCR detection
- Simple one-step master mix setup
- Fast turnaround in 1.5 hours
Organizations in need of reagents or complete workflow for consolidated COVID-19 testing should inquire here:
covid19requests@zymoresearch.com
SARS-CoV-2 Detection Test by Pangea Laboratory LLC
Pangea Laboratory is offering a SARS-CoV-2 Detection Test using Zymo Research’s DNA/RNA Shield™ Collection Devices, Quick-DNA/RNA Viral MagBead Extraction Kit, and Quick SARS-CoV-2 rRT-PCR Test Kit as a Lab Developed Test (LDT).
- Validated for throat swab and sputum samples (collected by healthcare professionals).
- Available for sample processing in the US only (excludes MD, PA, RI and NY States).
- SARS-CoV-2 test workflow can be adopted and validated by any clinical testing facility.
Organizations should request Sample Collection Kits for COVID-19 testing for its members or employees here: https://www.pangealab.com
Frequently Asked Questions
Are your products FDA-cleared?
Zymo Research’s products are considered for research use only.
Because the virus (SARS-CoV-2) causing COVID-19 is new, there are no FDA-cleared or approved tests to diagnose or detect it. However, during public health emergencies the FDA is able to issue Emergency Use Authorizations (EUAs) which allows test manufacturers to distribute potentially life-saving technologies prior to clearance or approval after the performance characteristics have already been validated. You can find more information at www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Zymo Research is actively working with the FDA to have an EUA approved for a SARS-CoV-2 detection test with its corresponding workflow. This workflow includes DNA/RNA Shield Collection Devices, Quick-DNA/RNA Viral MagBead Kit (R2140), and the Quick-SARS-CoV-2 rRT-PCR Test Kit.
Health organizations have validated Zymo Research’s sample collection and viral extraction kits in their workflows for clinical specimen collection and processing. For the adoption of Zymo products into EUA workflows, further validation on the product’s performance are required. Feel free to contact us, for additional information or assistance: covid19requests@zymoresearch.com.
What viral extraction kits do you recommend?
We offer a variety of viral extraction kit formats for both DNA and RNA. For high-throughput, automatable options, we highly recommend our Quick-DNA/RNA Viral MagBead Kit. Our technical support team is standing by to assist with any product inquiries: tech@zymoresearch.com.
What automatable options do you provide for viral extraction?
For high-throughput, automatable options, we recommend our Quick-DNA/RNA Viral MagBead Kit. Scripts are available for Tecan, Hamilton, and KingFisher automated platforms. Please contact our automation specialists for further support: automation@zymoresearch.com.
Can you support our COVID-19 testing lab or project?
Yes. We have a dedicated team of specialists readily available to assist you with questions regarding product availability, product recommendations and regulatory requirements. Please email covid19requests@zymoresearch.com.
Are your products FDA-cleared?
Zymo Research’s products are considered for research use only.
Because the virus (SARS-CoV-2) causing COVID-19 is new, there are no FDA-cleared or approved tests to diagnose or detect it. However, during public health emergencies the FDA is able to issue Emergency Use Authorizations (EUAs) which allows test manufacturers to distribute potentially life-saving technologies prior to clearance or approval after the performance characteristics have already been validated. You can find more information at www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Zymo Research is actively working with the FDA to have an EUA approved for a SARS-CoV-2 detection test with its corresponding workflow. This workflow includes DNA/RNA Shield Collection Devices, Quick-DNA/RNA Viral MagBead Kit (R2140), and the Quick-SARS-CoV-2 rRT-PCR Test Kit.
Health organizations have validated Zymo Research’s sample collection and viral extraction kits in their workflows for clinical specimen collection and processing. For the adoption of Zymo products into EUA workflows, further validation on the product’s performance are required. Feel free to contact us, for additional information or assistance: covid19requests@zymoresearch.com.
What viral extraction kits do you recommend?
We offer a variety of viral extraction kit formats for both DNA and RNA. For high-throughput, automatable options, we highly recommend our Quick-DNA/RNA Viral MagBead Kit. Our technical support team is standing by to assist with any product inquiries: tech@zymoresearch.com.
What automatable options do you provide for viral extraction?
For high-throughput, automatable options, we recommend our Quick-DNA/RNA Viral MagBead Kit. Scripts are available for Tecan, Hamilton, and KingFisher automated platforms. Please contact our automation specialists for further support: automation@zymoresearch.com.
Can you support our COVID-19 testing lab or project?
Yes. We have a dedicated team of specialists readily available to assist you with questions regarding product availability, product recommendations and regulatory requirements. Please email covid19requests@zymoresearch.com.
In the News
Stay up-to date on ways Zymo Research is partnering with the scientific community to help in the COVID-19 efforts.
#UnitedAgainstCOVID19
Extraction kits, test kits and a vaccine are only part of the solution when it comes to ending the COVID-19 pandemic. The best chance we have of winning the war against this virus is to stand united and hold one another accountable for social distancing to reduce risk of transmission.
Tag us on social media to share how you’re helping the fight against COVID-19
